Marker Therapeutics (MRKR)

• Market cap: $22.3M
• 1 day: -1.47%
• 5 days: -2.9%
• 1 month: -10.67%
• 3 months: 6.35%
• 6 months: 39.58%
• Year to date: -12.99%
• 1 year: 5.51%
• 5 years: -92.56%
• 10 years: -97.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Employees: 5